Please use this identifier to cite or link to this item: https://doi.org/10.1007/s10637-007-9085-0
Title: A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells
Authors: Ma, B.
Lam, K.C.
Mo, F.
Chan, A.T.C.
Zee, B.
Mok, T.
Goh, B.C. 
Soo, R.
Wang, L.Z.
Tan, E.H.
Leong, S.S.
Keywords: 3-AP
Gemcitabine
Methemoglobinemia
Non-small-cell lung cancer
Triapine
Issue Date: 2008
Citation: Ma, B., Lam, K.C., Mo, F., Chan, A.T.C., Zee, B., Mok, T., Goh, B.C., Soo, R., Wang, L.Z., Tan, E.H., Leong, S.S. (2008). A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells. Investigational New Drugs 26 (2) : 169-173. ScholarBank@NUS Repository. https://doi.org/10.1007/s10637-007-9085-0
Source Title: Investigational New Drugs
URI: http://scholarbank.nus.edu.sg/handle/10635/27208
ISSN: 01676997
DOI: 10.1007/s10637-007-9085-0
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

111
checked on Feb 15, 2020

WEB OF SCIENCETM
Citations

103
checked on Feb 7, 2020

Page view(s)

230
checked on Feb 19, 2020

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.